Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Developed by Metabolic Pharmaceuticals in Australia, AOD-9604 was engineered to retain the fat-reducing properties of intact growth hormone while eliminating the undesirable effects on glucose metabolism, insulin sensitivity, and tissue growth
Treatment-specific consent is required by the GMC and CQC to demonstrate that patients were informed about the exact procedure they received, including its specific ingredients, risks, and limitations
Jastreboff, C
[PMID: 31356792] PubMed record related to this compound for laboratory literature review
)
US$ 25.63
US$ 23.22
US$ 26.03
US$ 21.59
US$ 23.08
US$ 26.23
US$ 28.50
US$ 24.93
US$ 23.18
